CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis

Abstract: The Hermes receptor CD44 is a multifunctional adhesion molecule that plays an essential role in the homing and invasion of neoplastic stem cells in various myeloid malignancies. Although mast cells (MCs) reportedly express CD44, little is known about the regulation and function of this rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Müller, Niklas (VerfasserIn) , Jawhar, Mohamad (VerfasserIn) , Reiter, Andreas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Blood
Year: 2018, Jahrgang: 132, Heft: 18, Pages: 1936-1950
ISSN:1528-0020
DOI:10.1182/blood-2018-02-833582
Online-Zugang:Verlag, Pay-per-use, Volltext: https://doi.org/10.1182/blood-2018-02-833582
Verlag, Pay-per-use, Volltext: http://www.bloodjournal.org/content/132/18/1936
Volltext
Verfasserangaben:Niklas Mueller, Daniel Wicklein, Gregor Eisenwort, Mohamad Jawhar, Daniela Berger, Gabriele Stefanzl, Georg Greiner, Alexandra Boehm, Christoph Kornauth, Leonhard Muellauer, Susanne Sehner, Gregor Hoermann, Wolfgang R. Sperr, Philipp B. Staber, Ulrich Jaeger, Johannes Zuber, Michel Arock, Udo Schumacher, Andreas Reiter, and Peter Valent

MARC

LEADER 00000caa a2200000 c 4500
001 1665284323
003 DE-627
005 20230427000755.0
007 cr uuu---uuuuu
008 190513s2018 xx |||||o 00| ||eng c
024 7 |a 10.1182/blood-2018-02-833582  |2 doi 
035 |a (DE-627)1665284323 
035 |a (DE-599)KXP1665284323 
035 |a (OCoLC)1341212972 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Müller, Niklas  |e VerfasserIn  |0 (DE-588)1186000996  |0 (DE-627)1665285745  |4 aut 
245 1 0 |a CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis  |c Niklas Mueller, Daniel Wicklein, Gregor Eisenwort, Mohamad Jawhar, Daniela Berger, Gabriele Stefanzl, Georg Greiner, Alexandra Boehm, Christoph Kornauth, Leonhard Muellauer, Susanne Sehner, Gregor Hoermann, Wolfgang R. Sperr, Philipp B. Staber, Ulrich Jaeger, Johannes Zuber, Michel Arock, Udo Schumacher, Andreas Reiter, and Peter Valent 
264 1 |c 2018 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.05.2019 
520 |a Abstract: The Hermes receptor CD44 is a multifunctional adhesion molecule that plays an essential role in the homing and invasion of neoplastic stem cells in various myeloid malignancies. Although mast cells (MCs) reportedly express CD44, little is known about the regulation and function of this receptor in neoplastic cells in systemic mastocytosis (SM). We found that clonal CD34+/CD38− stem cells, CD34+/CD38+ progenitor cells, and CD117++/CD34− MCs invariably express CD44 in patients with indolent SM (ISM), SM with an associated hematologic neoplasm, aggressive SM, and MC leukemia (MCL). In addition, all human MCL-like cell lines examined (HMC-1, ROSA, and MCPV-1) displayed cytoplasmic and cell-surface CD44. We also found that expression of CD44 in neoplastic MCs depends on RAS-MEK and STAT5 signaling and increases with the aggressiveness of SM. Correspondingly, higher levels of soluble CD44 were measured in the sera of patients with advanced SM compared with ISM or cutaneous mastocytosis and were found to correlate with overall and progression-free survival. To investigate the functional role of CD44, a xenotransplantation model was employed using severe combined immunodeficient (SCID) mice, HMC-1.2 cells, and a short hairpin RNA (shRNA) against CD44. In this model, the shRNA-mediated knockdown of CD44 resulted in reduced MC expansion and tumor formation and prolonged survival in SCID mice compared with HMC-1.2 cells transduced with control shRNA. Together, our data show that CD44 is a RAS-MEK/STAT5-driven MC invasion receptor that correlates with the aggressiveness of SM. Whether CD44 can serve as therapeutic target in advanced SM remains to be determined in forthcoming studies. 
700 1 |a Jawhar, Mohamad  |d 1986-  |e VerfasserIn  |0 (DE-588)1046172905  |0 (DE-627)775847747  |0 (DE-576)399437061  |4 aut 
700 1 |a Reiter, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)172629551  |0 (DE-627)697563766  |0 (DE-576)133488594  |4 aut 
773 0 8 |i Enthalten in  |t Blood  |d Washington, DC : American Society of Hematology, 1946  |g 132(2018), 18, Seite 1936-1950  |h Online-Ressource  |w (DE-627)266886647  |w (DE-600)1468538-3  |w (DE-576)075961938  |x 1528-0020  |7 nnas  |a CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis 
773 1 8 |g volume:132  |g year:2018  |g number:18  |g pages:1936-1950  |g extent:15  |a CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis 
856 4 0 |u https://doi.org/10.1182/blood-2018-02-833582  |x Verlag  |x Resolving-System  |z Pay-per-use  |3 Volltext 
856 4 0 |u http://www.bloodjournal.org/content/132/18/1936  |x Verlag  |z Pay-per-use  |3 Volltext 
951 |a AR 
992 |a 20190513 
993 |a Article 
994 |a 2018 
998 |g 172629551  |a Reiter, Andreas  |m 172629551:Reiter, Andreas  |d 60000  |d 61200  |e 60000PR172629551  |e 61200PR172629551  |k 0/60000/  |k 1/60000/61200/  |p 19 
998 |g 1046172905  |a Jawhar, Mohamad  |m 1046172905:Jawhar, Mohamad  |d 60000  |d 61200  |e 60000PJ1046172905  |e 61200PJ1046172905  |k 0/60000/  |k 1/60000/61200/  |p 4 
999 |a KXP-PPN1665284323  |e 3475485443 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Niklas Mueller, Daniel Wicklein, Gregor Eisenwort, Mohamad Jawhar, Daniela Berger, Gabriele Stefanzl, Georg Greiner, Alexandra Boehm, Christoph Kornauth, Leonhard Muellauer, Susanne Sehner, Gregor Hoermann, Wolfgang R. Sperr, Philipp B. Staber, Ulrich Jaeger, Johannes Zuber, Michel Arock, Udo Schumacher, Andreas Reiter, and Peter Valent"]},"note":["Gesehen am 13.05.2019"],"recId":"1665284323","person":[{"given":"Niklas","display":"Müller, Niklas","family":"Müller","role":"aut"},{"given":"Mohamad","family":"Jawhar","display":"Jawhar, Mohamad","role":"aut"},{"role":"aut","display":"Reiter, Andreas","family":"Reiter","given":"Andreas"}],"title":[{"title_sort":"CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis","title":"CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis"}],"physDesc":[{"extent":"15 S."}],"relHost":[{"origin":[{"dateIssuedDisp":"1946-","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","dateIssuedKey":"1946","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"part":{"extent":"15","year":"2018","issue":"18","volume":"132","text":"132(2018), 18, Seite 1936-1950","pages":"1936-1950"},"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"titleAlt":[{"title":"Blood online"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosisBlood","pubHistory":["1.1946 -"],"note":["Gesehen am 21.04.2023"],"recId":"266886647","corporate":[{"display":"American Society of Hematology","role":"isb"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"eki":["266886647"],"issn":["1528-0020"],"zdb":["1468538-3"]},"language":["eng"]}],"language":["eng"],"id":{"doi":["10.1182/blood-2018-02-833582"],"eki":["1665284323"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"2018"}]} 
SRT |a MUELLERNIKCD44ISARAS2018